Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1876 entries
Sorted by: Best Match Show Resources per page
Antibiotic resistance and virulence properties in Escherichia coli strains from cases of urinary tract infections.

African journal of infectious diseases

Olorunmola FO, Kolawole DO, Lamikanra A.
PMID: 24381720
Afr J Infect Dis. 2013;7(1):1-7. doi: 10.4314/ajid.v7i1.1.

This study determined E. coli resistance to commonly used antibiotics together with their virulence properties in Ile-Ife, Nigeria. A total of 137 E. coli isolates from cases of urinary tract infection were tested for their sensitivity to commonly used...

Cite
Olorunmola FO, Kolawole DO, Lamikanra A. Antibiotic resistance and virulence properties in Escherichia coli strains from cases of urinary tract infections. Afr J Infect Dis. 2013;7(1):1-7doi: 10.4314/ajid.v7i1.1.
Olorunmola, F. O., Kolawole, D. O., & Lamikanra, A. (2013). Antibiotic resistance and virulence properties in Escherichia coli strains from cases of urinary tract infections. African journal of infectious diseases, 7(1), 1-7. https://doi.org/10.4314/ajid.v7i1.1
Olorunmola, Felix Oluwasola, et al. "Antibiotic resistance and virulence properties in Escherichia coli strains from cases of urinary tract infections." African journal of infectious diseases vol. 7,1 (2013): 1-7. doi: https://doi.org/10.4314/ajid.v7i1.1
Olorunmola FO, Kolawole DO, Lamikanra A. Antibiotic resistance and virulence properties in Escherichia coli strains from cases of urinary tract infections. Afr J Infect Dis. 2013;7(1):1-7. doi: 10.4314/ajid.v7i1.1. PMID: 24381720; PMCID: PMC3647523.
Copy Download .nbib Format: NLM
Pharmacists' knowledge of the safety of antibiotics for systemic use.

The International journal of risk & safety in medicine

Yakimova Y.
PMID: 26639686
Int J Risk Saf Med. 2015;27:S11-2. doi: 10.3233/JRS-150670.

BACKGROUND: Patients decide to take antibiotics themselves in 21% of cases of acute respiratory viral infections, influenza and acute respiratory infections [1]. The main factor of drug purchase at a pharmacy is pharmacist's recommendation. In 14% of cases of...

Cite
Yakimova Y. Pharmacists' knowledge of the safety of antibiotics for systemic use. Int J Risk Saf Med. 2015;27:S11-2doi: 10.3233/JRS-150670.
Yakimova, Y. (2015). Pharmacists' knowledge of the safety of antibiotics for systemic use. The International journal of risk & safety in medicine, 27S11-2. https://doi.org/10.3233/JRS-150670
Yakimova, Y. "Pharmacists' knowledge of the safety of antibiotics for systemic use." The International journal of risk & safety in medicine vol. 27 (2015): S11-2. doi: https://doi.org/10.3233/JRS-150670
Yakimova Y. Pharmacists' knowledge of the safety of antibiotics for systemic use. Int J Risk Saf Med. 2015;27:S11-2. doi: 10.3233/JRS-150670. PMID: 26639686.
Copy Download .nbib Format: NLM
Irrational antibiotic prescribing: a local issue or global concern?.

EXCLI journal

Hashemi S, Nasrollah A, Rajabi M.
PMID: 26622211
EXCLI J. 2013 May 07;12:384-95. eCollection 2013.

Resistance to antibiotics is a major public-health concern and antibiotic use is being ever more recognized as the main discriminatory pressure driving this resistance. The aim was to assess the outpatient usage of antibiotics in teaching hospitals in various...

Cite
Hashemi S, Nasrollah A, Rajabi M. Irrational antibiotic prescribing: a local issue or global concern?. EXCLI J. 2013;12:384-95
Hashemi, S., Nasrollah, A., & Rajabi, M. (2013). Irrational antibiotic prescribing: a local issue or global concern?. EXCLI journal, 12384-95.
Hashemi, Shiva, et al. "Irrational antibiotic prescribing: a local issue or global concern?." EXCLI journal vol. 12 (2013): 384-95.
Hashemi S, Nasrollah A, Rajabi M. Irrational antibiotic prescribing: a local issue or global concern?. EXCLI J. 2013 May 07;12:384-95. eCollection 2013. PMID: 26622211; PMCID: PMC4659337.
Copy Download .nbib Format: NLM
Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014).

Turkish journal of urology

Yılmaz N, Ağuş N, Bayram A, Şamlıoğlu P, Şirin MC, Derici YK, Hancı SY.
PMID: 27011879
Turk J Urol. 2016 Mar;42(1):32-6. doi: 10.5152/tud.2016.90836.

OBJECTIVE: Urinary tract infections (UTIs) are among the most frequently seen community-acquired infections worldwide. E. coli causes 90% of urinary system infections. To guide the empirical therapy, the resistance pattern of E. coli responsible for community-acquired UTI was evaluated...

Cite
Yılmaz N, Ağuş N, Bayram A, et al. Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014). Turk J Urol. 2016;42(1):32-6doi: 10.5152/tud.2016.90836.
Yılmaz, N., Ağuş, N., Bayram, A., Şamlıoğlu, P., Şirin, M. C., Derici, Y. K., & Hancı, S. Y. (2016). Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014). Turkish journal of urology, 42(1), 32-6. https://doi.org/10.5152/tud.2016.90836
Yılmaz, Nisel, et al. "Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014)." Turkish journal of urology vol. 42,1 (2016): 32-6. doi: https://doi.org/10.5152/tud.2016.90836
Yılmaz N, Ağuş N, Bayram A, Şamlıoğlu P, Şirin MC, Derici YK, Hancı SY. Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014). Turk J Urol. 2016 Mar;42(1):32-6. doi: 10.5152/tud.2016.90836. PMID: 27011879; PMCID: PMC4791079.
Copy Download .nbib Format: NLM
Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection.

Open forum infectious diseases

Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC.
PMID: 26509182
Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113. doi: 10.1093/ofid/ofv113. eCollection 2015 Sep.

Background.  Antibiotic use predisposes patients to Clostridium difficile infections (CDI), and approximately 32% of these infections are community-associated (CA) CDI. The population-level impact of antibiotic use on adult CA-CDI rates is not well described. Methods.  We used 2011 active...

Cite
Dantes R, Mu Y, Hicks LA, et al. Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. Open Forum Infect Dis. 2015;2(3):ofv113doi: 10.1093/ofid/ofv113.
Dantes, R., Mu, Y., Hicks, L. A., Cohen, J., Bamberg, W., Beldavs, Z. G., Dumyati, G., Farley, M. M., Holzbauer, S., Meek, J., Phipps, E., Wilson, L., Winston, L. G., McDonald, L. C., & Lessa, F. C. (2015). Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. Open forum infectious diseases, 2(3), ofv113. https://doi.org/10.1093/ofid/ofv113
Dantes, Raymund, et al. "Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection." Open forum infectious diseases vol. 2,3 (2015): ofv113. doi: https://doi.org/10.1093/ofid/ofv113
Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC. Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113. doi: 10.1093/ofid/ofv113. eCollection 2015 Sep. PMID: 26509182; PMCID: PMC4551478.
Copy Download .nbib Format: NLM
Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets.

Pharmaceutics

Al-Tabakha MM, Fahelelbom KMS, Obaid DEE, Sayed S.
PMID: 28531119
Pharmaceutics. 2017 May 20;9(2). doi: 10.3390/pharmaceutics9020018.

Bacterial resistance and antibiotic drug effectiveness can be related to administering generic products with a subtherapeutic dose or poor in vivo drug release. The aim of this study was to investigate whether locally marketed amoxicillin tablets have the required...

Cite
Al-Tabakha MM, Fahelelbom KMS, Obaid DEE, et al. Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets. Pharmaceutics. 2017;9(2)doi: 10.3390/pharmaceutics9020018.
Al-Tabakha, M. M., Fahelelbom, K. M. S., Obaid, D. E. E., & Sayed, S. (2017). Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets. Pharmaceutics, 9(2), . https://doi.org/10.3390/pharmaceutics9020018
Al-Tabakha, Moawia M, et al. "Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets." Pharmaceutics vol. 9,2 (2017). doi: https://doi.org/10.3390/pharmaceutics9020018
Al-Tabakha MM, Fahelelbom KMS, Obaid DEE, Sayed S. Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets. Pharmaceutics. 2017 May 20;9(2). doi: 10.3390/pharmaceutics9020018. PMID: 28531119; PMCID: PMC5489935.
Copy Download .nbib Format: NLM
Comparative antibiogram of coagulase-negative Staphylococci (CNS) associated with subclinical and clinical mastitis in dairy cows.

Veterinary world

Bansal BK, Gupta DK, Shafi TA, Sharma S.
PMID: 27047108
Vet World. 2015 Mar;8(3):421-6. doi: 10.14202/vetworld.2015.421-426. Epub 2015 Mar 28.

AIM: The present study was planned to determine the in vitro antibiotic susceptibility of coagulase-negative Staphylococci (CNS) strains isolated from clinical and subclinical cases of mastitis in dairy cows. Antibiotic sensitivity profile will be helpful to recommend early therapy...

Cite
Bansal BK, Gupta DK, Shafi TA, et al. Comparative antibiogram of coagulase-negative Staphylococci (CNS) associated with subclinical and clinical mastitis in dairy cows. Vet World. 2015;8(3):421-6doi: 10.14202/vetworld.2015.421-426.
Bansal, B. K., Gupta, D. K., Shafi, T. A., & Sharma, S. (2015). Comparative antibiogram of coagulase-negative Staphylococci (CNS) associated with subclinical and clinical mastitis in dairy cows. Veterinary world, 8(3), 421-6. https://doi.org/10.14202/vetworld.2015.421-426
Bansal, B K, et al. "Comparative antibiogram of coagulase-negative Staphylococci (CNS) associated with subclinical and clinical mastitis in dairy cows." Veterinary world vol. 8,3 (2015): 421-6. doi: https://doi.org/10.14202/vetworld.2015.421-426
Bansal BK, Gupta DK, Shafi TA, Sharma S. Comparative antibiogram of coagulase-negative Staphylococci (CNS) associated with subclinical and clinical mastitis in dairy cows. Vet World. 2015 Mar;8(3):421-6. doi: 10.14202/vetworld.2015.421-426. Epub 2015 Mar 28. PMID: 27047108; PMCID: PMC4774854.
Copy Download .nbib Format: NLM
Fabrication & Characterization of 3D Electrospun Biodegradable Nanofibers for Wound Dressing, Drug Delivery and Other Tissue Engineering Applications.

Pharmaceutical nanotechnology

Abdallah O, Jalali F, Zamani S, Isamil HM, Ma S, Nasrallah GK, Younes HM.
PMID: 29052498
Pharm Nanotechnol. 2016;4(3):191-201. doi: 10.2174/2211738504666160720125322.

BACKGROUND: The use of electrospinning technology (ET) in fabrication of threedimensional biodegradable electrospun nanofibers scaffolds (BENS) has recently gained considerable attention in tissue engineering. BENS are superior to other existing scaffolds in tissue regeneration as they provide high surface...

Cite
Abdallah O, Jalali F, Zamani S, et al. Fabrication & Characterization of 3D Electrospun Biodegradable Nanofibers for Wound Dressing, Drug Delivery and Other Tissue Engineering Applications. Pharm Nanotechnol. 2016;4(3):191-201doi: 10.2174/2211738504666160720125322.
Abdallah, O., Jalali, F., Zamani, S., Isamil, H. M., Ma, S., Nasrallah, G. K., & Younes, H. M. (2016). Fabrication & Characterization of 3D Electrospun Biodegradable Nanofibers for Wound Dressing, Drug Delivery and Other Tissue Engineering Applications. Pharmaceutical nanotechnology, 4(3), 191-201. https://doi.org/10.2174/2211738504666160720125322
Abdallah, Oraib, et al. "Fabrication & Characterization of 3D Electrospun Biodegradable Nanofibers for Wound Dressing, Drug Delivery and Other Tissue Engineering Applications." Pharmaceutical nanotechnology vol. 4,3 (2016): 191-201. doi: https://doi.org/10.2174/2211738504666160720125322
Abdallah O, Jalali F, Zamani S, Isamil HM, Ma S, Nasrallah GK, Younes HM. Fabrication & Characterization of 3D Electrospun Biodegradable Nanofibers for Wound Dressing, Drug Delivery and Other Tissue Engineering Applications. Pharm Nanotechnol. 2016;4(3):191-201. doi: 10.2174/2211738504666160720125322. PMID: 29052498.
Copy Download .nbib Format: NLM
Enhancing Phenotypic Detection of ESBL in AmpC co-producers by using Cefepime and Tazobactam.

Journal of clinical and diagnostic research : JCDR

Kaur J, Mahajan G, Chand K, Sheevani, Chopra S.
PMID: 26894064
J Clin Diagn Res. 2016 Jan;10(1):DC05-8. doi: 10.7860/JCDR/2016/15264.7041. Epub 2016 Jan 01.

INTRODUCTION: Routine phenotypic methods employing clavulanate and third generation cephalosporins to detect ESBL are not promising for isolates that co-produce an inhibitor-resistant beta lactamase like AmpC.AIM: Enhancing phenotypic detection of ESBL in AmpC co-producers by using cefepime and tazobactam.MATERIALS...

Cite
Kaur J, Mahajan G, Chand K, et al. Enhancing Phenotypic Detection of ESBL in AmpC co-producers by using Cefepime and Tazobactam. J Clin Diagn Res. 2016;10(1):DC05-8doi: 10.7860/JCDR/2016/15264.7041.
Kaur, J., Mahajan, G., Chand, K., Sheevani, & Chopra, S. (2016). Enhancing Phenotypic Detection of ESBL in AmpC co-producers by using Cefepime and Tazobactam. Journal of clinical and diagnostic research : JCDR, 10(1), DC05-8. https://doi.org/10.7860/JCDR/2016/15264.7041
Kaur, Jaspal, et al. "Enhancing Phenotypic Detection of ESBL in AmpC co-producers by using Cefepime and Tazobactam." Journal of clinical and diagnostic research : JCDR vol. 10,1 (2016): DC05-8. doi: https://doi.org/10.7860/JCDR/2016/15264.7041
Kaur J, Mahajan G, Chand K, Sheevani, Chopra S. Enhancing Phenotypic Detection of ESBL in AmpC co-producers by using Cefepime and Tazobactam. J Clin Diagn Res. 2016 Jan;10(1):DC05-8. doi: 10.7860/JCDR/2016/15264.7041. Epub 2016 Jan 01. PMID: 26894064; PMCID: PMC4740591.
Copy Download .nbib Format: NLM
Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?.

Gastroenterology research and practice

Rakici H, Akdogan RA, Ayaz T, Bedir R.
PMID: 25861262
Gastroenterol Res Pract. 2015;2015:706507. doi: 10.1155/2015/706507. Epub 2015 Mar 15.

Aim. We designed this trial to find answers to the following questions. (1) Does the success rate decrease in a country where HP prevalence is high? (2) Can we provide benefit by simultaneously treating the partners of infected patients?...

Cite
Rakici H, Akdogan RA, Ayaz T, et al. Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?. Gastroenterol Res Pract. 2015;2015:706507doi: 10.1155/2015/706507.
Rakici, H., Akdogan, R. A., Ayaz, T., & Bedir, R. (2015). Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?. Gastroenterology research and practice, 2015706507. https://doi.org/10.1155/2015/706507
Rakici, Halil, et al. "Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?." Gastroenterology research and practice vol. 2015 (2015): 706507. doi: https://doi.org/10.1155/2015/706507
Rakici H, Akdogan RA, Ayaz T, Bedir R. Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?. Gastroenterol Res Pract. 2015;2015:706507. doi: 10.1155/2015/706507. Epub 2015 Mar 15. PMID: 25861262; PMCID: PMC4377513.
Copy Download .nbib Format: NLM
Spontaneous bilateral Achilles tendon rupture in a patient treated with oral levofloxacin.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology

Salvi AE, Metelli GP, Bosco A, Berizzi A, Hacking SA, Cantalamessa A.
PMID: 27519893
J Orthop Traumatol. 2007 Jun;8(2):86-90. doi: 10.1007/s10195-007-0168-7. Epub 2007 Jun 08.

A case of bilateral rupture of the Achilles tendon in a patient treated with levofloxacin for cystitis is reported. A 76-year-old woman suddenly developed painful ankles one day after levofloxacin treatment. Drug therapy was switched to amoxicillin/clavulanate on the...

Cite
Salvi AE, Metelli GP, Bosco A, et al. Spontaneous bilateral Achilles tendon rupture in a patient treated with oral levofloxacin. J Orthop Traumatol. 2007;8(2):86-90doi: 10.1007/s10195-007-0168-7.
Salvi, A. E., Metelli, G. P., Bosco, A., Berizzi, A., Hacking, S. A., & Cantalamessa, A. (2007). Spontaneous bilateral Achilles tendon rupture in a patient treated with oral levofloxacin. Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology, 8(2), 86-90. https://doi.org/10.1007/s10195-007-0168-7
Salvi, A E, et al. "Spontaneous bilateral Achilles tendon rupture in a patient treated with oral levofloxacin." Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology vol. 8,2 (2007): 86-90. doi: https://doi.org/10.1007/s10195-007-0168-7
Salvi AE, Metelli GP, Bosco A, Berizzi A, Hacking SA, Cantalamessa A. Spontaneous bilateral Achilles tendon rupture in a patient treated with oral levofloxacin. J Orthop Traumatol. 2007 Jun;8(2):86-90. doi: 10.1007/s10195-007-0168-7. Epub 2007 Jun 08. PMID: 27519893; PMCID: PMC4484540.
Copy Download .nbib Format: NLM
The resistance rates of urinary tract infections: Our data from year 2010.

Turkish journal of urology

Doğru A, Karatoka B, Ergen P, Şen Aydın Ö, Tigen ET.
PMID: 26328117
Turk J Urol. 2013 Dec;39(4):237-43. doi: 10.5152/tud.2013.060.

OBJECTIVE: More than 95% of all urinary tract infections are caused by a single bacterium. Although E. coli is the most common bacterium causing community-acquired infections, Klebsiella spp., enteric gram-negative bacteria and S. saprophyticus have been also identified. This...

Cite
Doğru A, Karatoka B, Ergen P, et al. The resistance rates of urinary tract infections: Our data from year 2010. Turk J Urol. 2013;39(4):237-43doi: 10.5152/tud.2013.060.
Doğru, A., Karatoka, B., Ergen, P., Şen Aydın, �. �., & Tigen, E. T. (2013). The resistance rates of urinary tract infections: Our data from year 2010. Turkish journal of urology, 39(4), 237-43. https://doi.org/10.5152/tud.2013.060
Doğru, Arzu, et al. "The resistance rates of urinary tract infections: Our data from year 2010." Turkish journal of urology vol. 39,4 (2013): 237-43. doi: https://doi.org/10.5152/tud.2013.060
Doğru A, Karatoka B, Ergen P, Şen Aydın Ö, Tigen ET. The resistance rates of urinary tract infections: Our data from year 2010. Turk J Urol. 2013 Dec;39(4):237-43. doi: 10.5152/tud.2013.060. PMID: 26328117; PMCID: PMC4548602.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1876 entries